Renal System

  • Fiona Reid
Part of the Pediatric Oncology book series (PEDIATRICO, volume 22)


Partial Nephrectomy Hemolytic Uremic Syndrome Graft Versus Host Disease Radical Nephrectomy Nephrogenic Diabetes Insipidus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Allwood M, Stanley A, Wright P (1997) The Cytotoxics Handbook 3rd edn. Radcliffe Medical Press, OxfordGoogle Scholar
  2. Beauchamp D, Labrecque G (2001) Aminoglycoside nephrotoxicity: do time and frequency of administration matter? Current Opinion in Critical Care 7(6): 401–408CrossRefPubMedGoogle Scholar
  3. Bergstein JM (1996) Toxic nephropathies: renal failure, pp 1513–1514. In Nelson W, Behrman R, Kliegman R, Arvin A (eds) Textbook of Pediatrics, 15th edn. W.B. Saunders, PhiladelphiaGoogle Scholar
  4. Borsi JD (1994a) Clinical pharmacology of anticancer drugs in children I. Antimetabolites, p 186. In Pochedly C. (ed) Neoplastic Diseases of Childhood, vol.1. Harwood Academic, SwitzerlandGoogle Scholar
  5. Borsi JD (1994b: Principles of administration and monitoring chemotherapy in children, pp 175–181. In Pochedly C. (ed) Neoplastic Diseases of Childhood Vol.1. Harwood Academic, SwitzerlandGoogle Scholar
  6. Cachat F, Guignard JP (1996) The kidney in children under chemotherapy. Review Medicale de la Suisse Romande 116:985–993Google Scholar
  7. Campbell SC, Novick AC, Streem SB, Klein E, Licht M (1994) Complications of nephron-sparing surgery for renal tumors. Journal of Urology 151: 1177–1180PubMedGoogle Scholar
  8. Capra ML, Walker DA, Mohammed WM, Kapila L, Barbor PR, Sokal M, Robson K, Hewitt M, Stewart R. (1999) Wilms’tumor: a 25-year review of the role of pre-operative chemotherapy. Journal of Pediatric Surgery 34(4): 579–582PubMedGoogle Scholar
  9. Cassady JR(1995) Clinical radiation nephropathy. International Journal of Radiation Oncology, Biology and Physics 31:1249–1256Google Scholar
  10. Cohen EP, Lawton CA, Moulder JE (1995) Bone marrow transplant nephropathy: radiation nephritis revisited. Nephron 70(2): 217–222PubMedGoogle Scholar
  11. Coppes MJ, Zandvoort SWH, Sparling CR, Poon AO, Weitzman S, Blanchette VS (1993) Acquired von Willebrand disease in Wilms’tumor patients. Journal of Clinical Oncology 10: 1–7Google Scholar
  12. Doubek M, Mayer J, Horky D (2002) Safety of long-term administration of conventional amphotericin B in oncology patients. Casopsis Lekaru Ceskych 141(5): 156–159Google Scholar
  13. Ebb D, Green D, Shamberger R, Tarbell N (2001) Solid tumors of childhood, ch 44.2. In DeVita (ed) Principles and Practice of Oncology, 6th edn. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
  14. Godzinski J, Weirich A, Tournade M-F, Gauthier F, Buerger D, Moorman-Voestermans CGM, De Kraker J, Voute P, Ludwig R, Sawicz-Birkowska K, Vujanic G, Ducourtieux M (2001) Primary nephrectomy for emergency: a rare event in the international society of paediatric oncology nephroblastoma trial and study no.9. European Journal of Pediatric Surgery 11(1): 36–39PubMedGoogle Scholar
  15. Gonzalez-Fraile MI, Canizo C, Caballero D, Hernandez R, Vazquez L, Lopez C, Izarra A, Arroyo JL, de la Loma A, Otero MJ, San Miguel JF (2001) Cidofovir treatment of human polyomavirus-associated acute haemorrhagic cystitis. Transplant Infectious Disease 3(1):44–6Google Scholar
  16. Goren MP, Wright RK, Horowitz ME, Pratt CB (1987) Ifosfamide-induced subclinical tubular nephrotoxicity despite mesna. Cancer Treat Rep. 71(2):127–30PubMedGoogle Scholar
  17. Haselberger MB, Schwinghammer TL (1995) Efficacy of mesna for prevention of hemorrhagic cystitis after high-dose cyclophosphamide therapy. Annals of Pharmacotherapy 29(9):918–21PubMedGoogle Scholar
  18. Ignoffo RJ, Viele CS, Dallon LE, Venook A (1998) Cancer Chemotherapy Pocket Guide. Lippincott-Raven, PhiladelphiaGoogle Scholar
  19. Labuhn K, Valanis B, Schoeny R (1998) Nurses’ and pharmacists’ exposure to antineoplastic drugs: findings from industrial hygiene scans and urine mutagenicity tests (research on risks of handling cytotoxic drugs) Cancer Nursing 21(2): 79–89 (1998)Google Scholar
  20. Leung AY, Mak R, Lie AK, Yuen KY, Cheng VC, Liang R, Kwong YL (2002) Clinicopathological features and risk factors of clinically overt haemorrhagic cystitis complicating bone marrow transplantation. Bone Marrow Transplantation 29(6):509–13PubMedGoogle Scholar
  21. Loebstein R, Atanackovic G, Bishai R, Wolpin J, Khattak S, Hashemi G, Gobrial M, Baruchel S, Ito S, Koren G (1999) Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children. Journal of Clinical Pharmacology 39(5): 454–461PubMedGoogle Scholar
  22. Magrath I, Sandlund J, Raynor A, Rosenberg S, Arasi V, Miser J (1986) A phase II study of ifosfamide in the treatment of recurrent sarcomas in young people. Cancer Chemotherapy and Pharmacology 18(Suppl 2):S25–8PubMedGoogle Scholar
  23. Mitchell CD (1997) Wilms’tumor. In Pinkerton CR, Plowman PN (eds). Paediatric Oncology: Clinical Practice and Controversies. Chapman and Hall, LondonGoogle Scholar
  24. Murphy CP, Cox RL, Harden EA, Stevens DA, Heye MM, Herzig RH (1992) Encephalopathy and seizures induced by intravesical alum irrigations. Bone Marrow Transplantation 10(4):383–5PubMedGoogle Scholar
  25. Neonatal and Paediatric Pharmaceutical Group (2001) Medicines for Children RCPCH Publications, London.Google Scholar
  26. Newell DR, Pearson ADJ, Balmanno K, Price L, Wyllie RA, Keir M, Calvert AH, Lewis IJ, Pinkerton CR, Stevens MC (1993) Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children’s Cancer Study Group. Journal of Clinical Oncology 11(12):2314–23PubMedGoogle Scholar
  27. Nies A, Spielberg S (1996) Principles of Therapeutics, p. 50. In Hardman J, Limbird L, Molinoff P, Ruddon R, Goodman Gilman A: The Pharmacological Basis Of Therapeutics, 9th edn. McGraw-Hill, New YorkGoogle Scholar
  28. Oyama Y, Komatsuda A, Imai H, Ohtani H, Kamai K, Wakini H, Miura AB, Nakamoto Y (1996) Late onset bone marrow transplant nephropathy Internal Medicine 35: 489–493Google Scholar
  29. Relling MV, Schunk JE (1986) Drug-induced hemorrhagic cystitis. Clinical Pharmacy 5: 590PubMedGoogle Scholar
  30. Ritchey ML, Lally KP, Haase GM, Shochat SJ, Kelalis PP (1992) Superior mesenteric artery injury during nephrectomy for Wilms’tumor. Journal of Pediatric Surgery 27(5): 612–615PubMedGoogle Scholar
  31. Sanders WH, Anderson C (1988) A simple nephrectomy. In Glenn J and Graham S (eds) Glenn’s Urologic Surgery. Lippincott-Raven, PhiladelphiaGoogle Scholar
  32. Skinner R, Pearson ADJ, English MW, Price L, Wyllie RA, Coulthard MG, Craft AW (1998) Cisplatin dose rate as a factor for nephrotoxicity in children. British Journal of Cancer 77(10): 1677–1682PubMedGoogle Scholar
  33. Tortorice PV (1997) Chemotherapy: principles of therapy, p. 299–301. In Groenwald S, Hansen Frogge M, Goodman M, Henke Yarbro C (eds). Cancer Nursing: Principles and Practice, 4th edn. Jones and Bartlett, Sudbury, MAGoogle Scholar
  34. Traxer O, Desgrandchamps F, Sebe P, Haab F, Le Duc A, Gattegno B, Thibault P (2001) [Hemorrhagic cystitis: etiology and treatment.] [article in French] Progres en Urologie 11(4):591–601Google Scholar
  35. Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D, Pappas P, Seibel N, Greenberg RN, Dummer S, Schuster M, Holcenberg JS, Dismukes WE (1999) Liposomal amphoterecin B for empirical therapy in patients with persistent fever and neutropenia. The New England Journal of Medicine 340(10): 764–771PubMedGoogle Scholar
  36. Wood PA, Hrushesky WJM (1996) Circadian rhythms and cancer chemotherapy. Critical Reviews in Eukaryotic Gene Expression 6(4): 299–343PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Fiona Reid

There are no affiliations available

Personalised recommendations